10 Total results for product and free and sample content found
Datamonitor Healthcare
By Colin White, Robert Jeng & Jolene Lau 28 Jul 2022
This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well
Topic immuno-oncology
Datamonitor Healthcare, Biomedtracker
By Hardik Patel 15 Jul 2019
Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.
Scrip
02 Aug 2017
The US FDA has approved BMS' Opdivo for previously treated patients with some forms of colorectal cancer, however direct competition from Merck's Keytruda may limit its success.
Topic immuno-oncology Cancer
Scrip
By Lucie Ellis 26 Jul 2017
Leading immunotherapy agents are beginning to report early-stage data from monotherapy and combination trials in advanced cervical cancer – a treatment area with very few approved options.
Topic Cancer immuno-oncology Research & Development Strategy
Scrip
By Joseph Haas 13 Feb 2017
New cancer immunotherapies are doing well in lung cancer, with Merck's Keytruda picking up share in the first-line setting and Roche's Tecentriq in second-line. Bristol-Myers Squibb is banking on combo therapy to restore its momentum.
Topic immuno-oncology
Scrip
12 Dec 2016
Delivering clinical advances in areas including immuno-oncology and Alzheimer's disease data while navigating the stormy seas of global politics could represent an opportunity for pharma to influence change. An uptick in sector M&A could also ensue if Trump offers US corporations a tax holiday.
Topic immuno-oncology
Scrip
By Jessica Merril 10 Oct 2016
Merck’s strong Phase II data testing Keytruda with chemotherapy
Topic immuno-oncology
Topic immuno-oncology
Datamonitor Healthcare
13 Sep 2015
Entering an established market as a new player can be daunting. Often it's difficult to know exactly where you should be targeting your trial, and also what patient group you should be targeting your treatment at.
Topic immuno-oncology
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: